AVIR: Atea Pharmaceuticals, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Atea Pharmaceuticals, Inc.

NASDAQ:AVIR

SummaryFactSheetFinancial
Price
$5.65
Loss Chance
59.1%
1.82JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
ANI Pharmaceuticals
NASDAQ:ANIP
4.91
$84.06
47.45%
Bausch Health Companies
NYSE:BHC
5.05
$5.65
79.32%
Collegium Pharmaceutical
NASDAQ:COLL
5.32
$36.51
89.59%
GSK plc
NYSE:GSK
6.96
$50.53
44.81%
Jazz Pharmaceuticals plc
NASDAQ:JAZZ
5.18
$228.57
41.96%
Jitta Factors
Growth Opportunity (12)
Recent Business Performance (28)
Financial Strength (29)
Return to Shareholders (11)
Competitive Advantage (13)
Jitta Signs
Cash Conversion CycleLess than 30 days
Recent Business PerformanceEarning decline 193.51% in the last quarter (yoy)
Key Stats
Jitta Score
Jitta Line
1.82
100.00%
3.12
99.44%
3.07
154.49%
Pharmaceuticals
4.91
47.45%
5.05
79.32%
5.32
89.59%
COMPANY DESCRIPTION
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). The company also developing AT-587, that is in Phase 1 clinical trial for the treatment of chronic HEV infection. In addition, it offers a proprietary platform of nucleosides and nucleotides for virology, medicinal chemistry, and antiviral drug development. The company has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
ateapharma.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.